SkinPen Treatment

The Gold Standard in Microneedling

The first clinically proven microneedling device to safely and effectively treat various skin concerns.

SkinPen addresses:

Ageing,
Fine Lines,
Wrinkles,
Scars,
Melasma,
Pigmentation

More about SkinPen...

What is a SkinPen Treatment?

SkinPen® Microneedling, also known as collagen induction therapy, is a minimally invasive skin rejuvenation procedure that helps minimize the signs of aging, improve the appearance of acne scars and rejuvenate aging skin.


What are the benefits?

Minimally invasive – Quick procedure at 20-30 minutes – Safe for all skin types. Improve fine lines and wrinkles – Helps clear up acne scaring – Younger looking skin. Less intense than chemical peels or lasers – Healing continues after the procedure is over.


How does it work?

SkinPen creates hundreds to thousands of “micro” skin punctures per second to stimulate the skin’s natural wound healing process – inflammation, proliferation, and remodeling – to prompt tissue remodeling without causing scar tissue formation.2 Most patients can return to normal activities within 24 hours.

Will it work for me?

Unlike some alternatives, SkinPen has been clinically proven to be effective for women and men with skin ranging from light to very dark. Likewise, unlike lasers or chemical peels that can damage skin over the long term, SkinPen treatments, when properly spaced and overseen by a physician, can be used for years.

Is it safe?

Yes, by design. SkinPen’s patent-pending – and single-use – sterile needle cartridge is built with safety in mind. SkinPen is also surrounded by a proprietary BioSheath that acts as a barrier to prevent cross contamination between procedures. That’s part of the reason SkinPen is the world’s first FDA-cleared microneedling device.

Who should not use it?

SkinPen should not be used on patients who have active skin cancer in the treatment area(s); open wounds, sores, or irritated skin in the treatment area(s); an allergy to stainless steel or 

anesthetics; a hemorrhagic (bleeding) disorder or hemostatic (bleeding) dysfunction; are pregnant or nursing; or are currently taking drugs with the ingredient isotretinoin (such as Accutane).